Related references
Note: Only part of the references are listed.Identification of tumor antigens with immunopeptidomics
Chloe Chong et al.
NATURE BIOTECHNOLOGY (2022)
Oncogenic cancer/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy
Ping Yang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)
Proteogenomic Analysis Unveils the HLA Class I-Presented Immunopeptidome in Melanoma and EGFR-Mutant Lung Adenocarcinoma
Yue A. Qi et al.
MOLECULAR & CELLULAR PROTEOMICS (2021)
The role of the cancer testis antigen PRAME in tumorigenesis and immunotherapy in human cancer
Yichi Xu et al.
CELL PROLIFERATION (2020)
Liquid Biopsy Based Single-Cell Transcriptome Profiling Characterizes Heterogeneity of Disseminated Tumor Cells from Lung Adenocarcinoma
Yu Dong et al.
PROTEOMICS (2020)
Rac-GEF/Rac Signaling and Metastatic Dissemination in Lung Cancer
Mariana Cooke et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Identification of Tumor Antigens in the HLA Peptidome of Patient-derived Xenograft Tumors in Mouse
Nataly Mancette Rijensky et al.
MOLECULAR & CELLULAR PROTEOMICS (2020)
Personal Neoantigen Cancer Vaccines: A Road Not Fully Paved
Edward F. Fritsch et al.
CANCER IMMUNOLOGY RESEARCH (2020)
SASH1 is a prognostic indicator and potential therapeutic target in non-small cell lung cancer
Joshua T. Burgess et al.
SCIENTIFIC REPORTS (2020)
Quantitative mass spectrometry to identify protein markers for diagnosis of malignant pleural mesothelioma
Reuben White et al.
JOURNAL OF PROTEOMICS (2019)
Malignant pleural effusion supernatant is an alternative liquid biopsy specimen for comprehensive mutational profiling
Zhihua Guo et al.
THORACIC CANCER (2019)
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma
Bracha Shraibman et al.
MOLECULAR & CELLULAR PROTEOMICS (2019)
Cancer Neoantigens
Ton N. Schumacher et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 37, 2019 (2019)
Malignant pleural effusion management: keeping the flood gates shut
Steven Walker et al.
Lancet Respiratory Medicine (2019)
Making cold malignant pleural effusions hot: driving novel immunotherapies
Pranav Murthy et al.
ONCOIMMUNOLOGY (2019)
Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry
Lena Katharina Freudenmann et al.
IMMUNOLOGY (2018)
Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis
Ioannis Psallidas et al.
LANCET ONCOLOGY (2018)
Pleural Disease
David Feller-Kopman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Massive expression of germ cell-specific genes is a hallmark of cancer and a potential target for novel treatment development
Jan Willem Bruggeman et al.
ONCOGENE (2018)
The Role of Mass Spectrometry and Proteogenomics in the Advancement of HLA Epitope Prediction
Amanda L. Creech et al.
PROTEOMICS (2018)
ALK-rearrangement in non-small-cell lung cancer (NSCLC)
Xue Du et al.
THORACIC CANCER (2018)
Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy
Olga Gordeeva
SEMINARS IN CANCER BIOLOGY (2018)
Quiescin Sulfhydryl Oxidase 1 (QSOX1) Secreted by Lung Cancer Cells Promotes Cancer Metastasis
Hye-Jin Sung et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Towards personalized, tumour-specific, therapeutic vaccines for cancer
Zhuting Hu et al.
NATURE REVIEWS IMMUNOLOGY (2018)
The biology and management of non-small cell lung cancer
Roy S. Herbst et al.
NATURE (2018)
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
Valsamo Anagnostou et al.
CANCER DISCOVERY (2017)
Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction
Jennifer G. Abelin et al.
IMMUNITY (2017)
NetMHCpan-4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data
Vanessa Jurtz et al.
JOURNAL OF IMMUNOLOGY (2017)
Lung cancer: current therapies and new targeted treatments
Fred R. Hirsch et al.
LANCET (2017)
GibbsCluster: unsupervised clustering and alignment of peptide sequences
Massimo Andreatta et al.
NUCLEIC ACIDS RESEARCH (2017)
Genome-wide identification of cancer/testis genes and their association with prognosis in a pan-cancer analysis
Vandeclecio Lira da Silva et al.
ONCOTARGET (2017)
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
Alena Gros et al.
NATURE MEDICINE (2016)
High-sensitivity HLA class I peptidome analysis enables a precise definition of peptide motifs and the identification of peptides from cell lines and patients' sera
Danilo Ritz et al.
PROTEOMICS (2016)
Present Yourself! By MHC Class I and MHC Class II Molecules
Kenneth L. Rock et al.
TRENDS IN IMMUNOLOGY (2016)
Systematic identification of genes with a cancer-testis expression pattern in 19 cancer types
Cheng Wang et al.
NATURE COMMUNICATIONS (2016)
Profiling cancer testis antigens in non-small-cell lung cancer
Dijana Djureinovic et al.
JCI INSIGHT (2016)
Neuroepithelial transforming gene 1 functions as a potential prognostic marker for patients with non-small cell lung cancer
Li Fang et al.
MOLECULAR MEDICINE REPORTS (2015)
Oncogenic cancer/testis antigens: prime candidates for immunotherapy
Morten F. Gjerstorff et al.
ONCOTARGET (2015)
Antigen-specific activation and cytokine-facilitated expansion of naive, human CD8+ T cells
Matthias Woelfl et al.
NATURE PROTOCOLS (2014)
Vav1 promotes lung cancer growth by instigating tumor-microenvironment cross-talk via growth factor secretion
Shulamit Sebban et al.
ONCOTARGET (2014)
HLA ligandome tumor antigen discovery for personalized vaccine approach
Hans-Georg Rammensee et al.
EXPERT REVIEW OF VACCINES (2013)
Towards a knowledge-based Human Protein Atlas
Mathias Uhlen et al.
NATURE BIOTECHNOLOGY (2010)
Soluble plasma HLA peptidome as a potential source for cancer biomarkers
Michal Bassani-Sternberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
ToppGene Suite for gene list enrichment analysis and candidate gene prioritization
Jing Chen et al.
NUCLEIC ACIDS RESEARCH (2009)
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
Juergen Cox et al.
NATURE BIOTECHNOLOGY (2008)
Tumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands
M. Campoli et al.
TISSUE ANTIGENS (2008)
Modular stop and go extraction tips with stacked disks for parallel and multidimensional peptide fractionation in proteomics
Y Ishihama et al.
JOURNAL OF PROTEOME RESEARCH (2006)
Thyroid transcription factor 1 in pulmonary adenocarcinoma
G Stenhouse et al.
JOURNAL OF CLINICAL PATHOLOGY (2004)
Soluble HLA class I molecules in malignant pleural and peritoneal effusions and its possible role on NK and LAK cytotoxicity
Z Amirghofran et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2002)
Pleural effusion
RW Light
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Differential expression of human major histocompatibility class I loci: HLA-A, -B, and -C
DR Johnson
HUMAN IMMUNOLOGY (2000)
Share Paper
